Clinical Trials Browser

Phase 2 × Flucytosine × 1 year × Clear all

NCT06264388 2025-05-29

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Phase 2 Recruiting

Astrocytoma, Glioma